Skip to content
DNDi Logo
  • DNDi INTERNATIONAL
  • DNDi JAPAN
  • DNDi LATIN AMERICA
  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Menu
  • ABOUT DNDi
    • ABOUT DNDi NORTH AMERICA
    • OUR TEAM
    • BOARD OF DIRECTORS
    • OUR PUBLICATIONS
    • FINANCIALS
    • JOBS
    • Close
  • DISEASES & PROJECTS
  • ADVOCACY
  • MEDIA CENTER
  • DONATE
  • CONTACT
    • Close
  • Home

Media Center

RSS SCIENTIFIC ARTICLES

  • 2-aminobenzimidazoles for leishmaniasis: From initial hit discovery to in vivo profiling
  • Blood parasite load as an early marker to predict treatment response in visceral leishmaniasis in Eastern Africa
  • Drug-drug interaction study of benznidazole and E1224 in healthy male volunteers

RSS PRESS RELEASES

  • Largest clinical trial in Africa to treat COVID-19 cases before they become severe is launched in 13 countries
  • Thailand’s Prince Mahidol Award honours Dr Bernard Pécoul, Founder of DNDi, for his service to public health
  • COVID-19: first set of specific healthcare recommendations issued for people living with Chagas disease

RSS NEWS

RSS IN THE MEDIA

  • Toute la planète doit être vaccinée
  • Por qué en 9 años el Chagas podría dejar de ser una preocupación de salud pública mundial
  • Health Digest: The story of Dr. Monique Wasuna, Director DNDi Africa- Doctor’s Diary

RSS Scientific Articles

  • 2-aminobenzimidazoles for leishmaniasis: From initial hit discovery to in vivo profiling
  • Blood parasite load as an early marker to predict treatment response in visceral leishmaniasis in Eastern Africa
  • Drug-drug interaction study of benznidazole and E1224 in healthy male volunteers
  • Novel linker variants of antileishmanial/antitubercular 7-substituted 2-nitroimidazooxazines offer enhanced solubility

About DNDi

Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients’ needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected patients.

Subscribe

Sign up for the E-news newsletter! By subscribing, you agree that all info submitted will be processed according to our Privacy Policy. You can unsubscribe any time.

I want to receive

Connect

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube

DNDi Worldwide

  • DNDi regional offices
  • DNDi Japan のサイトへはこちらから.
  • DNDi Latin America website

Donate

Support research for neglected disease treatments by making a gift

Authorize.net Seal

Charity Status

GuideStar Gold Participantnewyork-ac-seal-vertical-black-web

Social Mission Ratio

DNDi social mission ratio 2019

  • PRIVACY POLICY
  • TERMS OF USE
  • ACCEPTABLE USE POLICY
  • COOKIE POLICY
  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License
We use cookies to improve your experience with our website. By continuing to browse our website, you are agreeing to our use of cookies. However, you can change your cookie settings at any time in your browser. Read Cookie Policy. Close